Akhil Chawla

12PUBLICATIONS
91CO-AUTHORS
Radiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 10, 2026
Impact of Institutional Radiotherapy Patient Volume on Postoperative and Oncologic Outcomes After Neoadjuvant Radiation for Pancreatic Cancer.

|Aug 26, 2026
KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer.

|Aug 25, 2026
Multimodal Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma (PDAC) With Vascular Involvement: What Is the Impact of Radiation on Perioperative Outcomes, Local Control, and Survival?

|Jun 30, 2026
High-Sensitivity ctDNA Analysis Uncovers Relevant Signals Missed by NGS in Pancreatic Cancer.

|Mar 06, 2025
Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.

Lakshmi Rajdev, Gentry G King, Christopher H Lieu

|Oct 29, 2024
Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer Patients Treated With Neoadjuvant Chemotherapy.

Dominic J Vitello, Dhavan Shah, Amy Wells

Pageof 2

Frequent Collaborators

2 joint publications

George Molina

2 joint publications

Lauren M Janczewski

2 joint publications

Qiang Zhang

1 joint publications

Ritchell van Dams